Sales Trigger: KROMATID’s $8M Series C Battle Card
KROMATID just landed $8M in Series C. Arm your pipeline with this battle card—decision-makers, pain points & pitch angles to drive your next touch and close faster.
Published on
Do not index
Do not index
🚀 Battle Card: KROMATID
Quick trigger:
👤 Decision Maker in the News
- Jim Chomas, CEO 📧 jchomas@kromatid.com
💡 Why It Matters
- The $8M injection extends R&D runway by ≈18 months, enabling imaging and bioinformatics platform enhancements—your prime KROMATID sales trigger. → Source
🎯 Core Pain Point
- Inability to detect chromosomal structural variants with high clarity
- Manual bioinformatics workflows slowing regulatory submissions
💰 What to Pitch
- Primary: High-throughput imaging analytics platform → Accelerated, ultra-precise structural variant detection
- Expansion: Integrated bioinformatics pipeline → Streamlined data analysis and faster regulatory approval
🗺️ Quick Context
- HQ: Longmont, CO
- Employees: ≈50
- Rev: ≈$5M
- Website: kromatid.com
🤼 Competitive Intel
Which other vendors you’ll probably face to win KROMATID’s business.
- Bionano Genomics — Optical Genome Mapping
- Unique edge: Ultra-high resolution SV detection
- Evaluated by Dir of Genomics for sensitivity benchmarks
- 10x Genomics — Linked-Read & Single-Cell Sequencing
- Unique edge: Single-cell structural analysis
- Evaluated by SVP R&D for cell therapy applications
- PacBio — Long-Read Sequencing
- Unique edge: High consensus accuracy for SVs
- Evaluated by Lab Ops for throughput demands
- Oxford Nanopore — Portable Long-Read Sequencing
- Unique edge: Rapid turnaround and field deployability
- Evaluated by Dir of Bioinformatics for pipeline integration
✅ Do-Now Checklist
Connect with all decision makers (Jim Chomas) on LinkedIn
Use “KROMATID sales trigger” in subject lines to tie timing to outreach
Generate email + DM with the Copy-My-Prompt block (Step 7) referencing this KROMATID sales trigger
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑<your company>❑
OFFER_BRIEF = ❑High-throughput imaging analytics platform❑
PROOF_METRIC = ❑≈ TBD❑
CTA_STYLE = ❑quick_call❑
TONE = ❑punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Jim
COMPANY = KROMATID
DEPT = ≈ TBD
SIZE = 50
BOTTLENECK = ≈ TBD
EVENT = Announces $8M Series C Round
DETAIL = Announces $8M Series C Round
PAIN = Inability to detect chromosomal structural variants with high clarity
SRC = https://vcnewsdaily.com/kromatid/venture-capital-funding/pdgrpynpcx
SIM_CO = ≈ TBD
WIN_METRIC = ❑≈ TBD❑
NEXT_SIZE = ≈ TBD
EMP_EST = 50
REV_EST = $5M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: 50-person ≈ TBD
Jim—noticed your ≈ TBD team is ≈ 50.
That’s when ≈ TBD slows growth.
We helped ≈ TBD fix this with High-throughput imaging analytics platform.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ TBD.
DM ≤45 words, TONE:
Saw your post about Announces $8M Series C Round — Inability to detect chromosomal structural variants with high clarity.
High-throughput imaging analytics platform. ≈ TBD.
Quick chat?